Top Medical Searches

Janssen drops U.S. lawsuit against Samsung Bioepis’ Remicade copy

SEOUL (Reuters) – A unit of healthcare conglomerate Johnson & Johnson has dropped a lawsuit it filed to block a copy of its rheumatoid arthritis drug Remicade produced by South Korea’s Samsung Bioepis Co Ltd from being sold in the United States.

 Read more…

Be Sociable, Share!
November 14th, 2017 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us